Log In
Print this Print this

CpG7909, PF-3512676

Also known as: formerly ProMune

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionToll-like receptor 9 (TLR9) agonist
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of ActionToll-like receptor 9 (TLR9) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationMelanoma
Indication DetailsTreat advanced malignant melanoma; Treat stage I/II melanoma; Treat stage IV melanoma; Treat stage IV metastatic melanoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today